Viewing Study NCT05583604


Ignite Creation Date: 2025-12-24 @ 9:19 PM
Ignite Modification Date: 2026-01-11 @ 8:35 AM
Study NCT ID: NCT05583604
Status: AVAILABLE
Last Update Posted: 2025-12-18
First Post: 2022-10-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Managed Access Programs for AIN457, Secukinumab
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module